Abstract
Background: P450 BM3 is a high activity enzyme with biotechnological potential. Results: Mutations perturbing P450 BM3's conformational state and active site facilitate human P450-like oxidation of the drug omeprazole. Conclusion: Conformational destabilization enables P450 BM3 to explore novel conformations and accept diverse substrates. Significance: " Gatekeeper" mutations that decrease the energetic barrier for transition to the substrate-bound state can reconfigure P450 BM3 specificity and reactivity. © 2013 by The American Society for Biochemistry and Molecular Biology, Inc.
Original language | English |
---|---|
Pages (from-to) | 25387-25399 |
Number of pages | 12 |
Journal | Journal of Biological Chemistry |
Volume | 288 |
Issue number | 35 |
DOIs | |
Publication status | Published - 30 Aug 2013 |